dine in four steps in 75% overall yield (Chart 1), according to published procedures. 4) The best coupling yields were obtained using the system benzotriazol-1-(yloxy)tris(pyrolidino)phosphoniumhexafluorophosphate/1-hydroxybenzotriazol (PyBop/HOBt) as the condensing agent in anhydrous N,N-dimethylformamide/N,N-diisopropylethylamine (DMF/DIEA), leading to compound 4 in 75% yield after purification. The successive treatment of 4 with the classic desilylating reagent TBAF in tetrahydrofuran (THF) to remove the TBDMS group led only to degradation products; however, the 3-OH group could be successful deprotected, but in low yield (32% after chromatography) with the addition of Et 3 N · 3HF in anhydrous THF. The purity and structure of all synthesized compounds were ascertained by 1 H-and 13 C-NMR analysis as well as by mass spectral data. 
Synthesis and Preliminary Biological Evaluation of a New

Results
Detection of Cytotoxicity, Apoptosis Induction, and Stability Assay The effects of compound 5 on cytotoxic activity were studied in vitro in SAOS cell line, and cell vitality was evaluated after different periods of continuous exposure to compound 5 50 mM. A SAOS parallel culture were treated with methanol only as an experimental control. Figure 2 shows the results obtained in triplicate cultures for each treatment. Cytotoxicity induced by 5 was time dependent; treatment with compound 5 50 mM reduced cell viability by 40% at 4 d and by 58% at 5 d of exposure, whereas no effect was found in the methanol-treated cell line. These results clearly indicate that compound 5 is highly cytotoxic in these conditions. To investigate whether the cytotoxic effect was due to apoptosis or another mechanism, nuclear morphology studies were performed using DAPI staining. After 4 d of treatment with the 5 SAOS cell line and parallel untreated culture 50 mM were stained as described in the Materials and Methods, and analyzed using an Axiophot fluorescence microscope with a 63ϫ1.4 NA plane Apochromat objective. No significant presence of apoptosis, in the form of condensed or fragmented nuclei, could be detected in response to treat-ment, as shown in Fig. 3 . Thus the lack of increase in apoptosis between treated and untreated cells may depend on p53 deficiency, as demonstrated in a previous report.
12) The present results indicate that compound 5 is potently cytotoxic in SAOS cells. Since these cells are p53 deficient, the mechanism(s) underlying cytotoxicity do not involve p53 activity. Topoisomerase inhibitors have been reported to induce the generation of hydrogen peroxide in target cells. 13) An analogous activity might be displayed by compound 5, leading to either cell necrosis or apoptosis-induced mitochondrial damage. 14) However, further investigations will be necessary to identify the interesting mechanism(s) through which compound 5 activates cytotoxicity and to determine in vivo how many prodrugs (or drugs derived from enzymatic hydrolysis) 15) are present in several organs of the guinea pig. The stability assay results demonstrated that compound 5 is stable at pH 7.4 and was hydrolyzed slowly in human plasma and transformed in the active compound. In this way, through the carrier, it is not hydrolyzed at the peripheral level, but shows greater activity in specific tumor cells. The enzyme cathepsin hydrolyzed the carbamidic bond, giving the active compound.
Experimental
General Column chromatography was performed on silica gel (Merck, Kieselgel 40, 0.063, 0.200 mm). TLC analysis was carried out on Merck Kieselgel 60 F254 0.25-mm plates, visualized with UV light.
For the electrospray ionization (ESI)-MS analysis, a Waters Micromass ZQ instrument equipped with an electrospray source was used in the positive and/or negative mode. NMR spectra were recorded on Bruker WM-400 and on Varian-Gemini 300 spectrophotometers. All chemical shifts are expressed in ppm with respect to the residual solvent signal. J values are given in Hz. UV measurements were performed on a Perkin.
Synthesis of 2 Compound 1 (30 mg, 0.073 mmol) was left in contact with 730 ml of a 0.1 M solution of NaOH in pyridine and stirred for 12 h at room temperature. The reaction was then quenched by the addition of 3.8 mg of NH 4 Cl, and the resulting mixture was concentrated under reduced pressure and purified on two silica gel plates eluted with CHCl 3 /CH 3 The mixture was then concentrated under reduced pressure and purified on three silica gel plates eluted with CHCl 3 /CH 3 OH 9 : 1 (v/v). The band at Rfϭ0.75 was scratched off the plates and eluted from silica with CHCl 3 /CH 3 OH 8 : 2 (v/v). After drying 23 mg (0.033 mmol, 75% yield) of 4 remained, and the purity was confirmed by TLC and NMR analysis. Compound 4 (23 mg, 0.033 mmol) was dissolved in anhydrous THF 500 ml and treated with 25 ml (0.16 mmol) of Et 3 N · 3HF overnight at room temperature. The crude reaction was diluted with THF, then dried, purified on two silica gel plates and eluted with CHCl 3 /CH 3 OH 85 : 15 (v/v). The band at Rfϭ0.6 was scratched off the plates, and eluted with CHCl 3 /CH 3 OH 8 : 2 (v/v).
The dried eluate afforded 6 mg (0.010 mmol, 32% yield) of 5, and the purity was confirmed by TLC and NMR analysis. . Elemental analyses was performed in our analytical labs and agreed with the theoretical values within Ϯ0.4%.
Stability Tests. Materials and Reagents Phosphate buffer pH 7.4 (50 mM) was adjusted with phosphoric acid. Methanol was purchased from Carlo Erba (Italy) (HPLC grade). Human plasma was purchased from LAS Laboratory (Sassari, Italy). Deionized and distilled water was purified through a Milli Q system (Millipore, Milford, MA, U.S.A.).
Chemical Stability Compound 5 methanolic solution 2 ml (0.5 mg/ml) was added to 4 ml of pH 7.4 phospate buffer. The solution was maintained at 37°C and aliquots were withdrawn every 1 h for the initial 6 h of incubation. The possible disappearance of the prodrug was determined with HPLC analysis using the method reported below. The prodrug concentrations were determined from the calibration curve constructed by standard solutions with known concentrations (Table 1) .
Enzymatic Stability A 4-ml volume of plasma was measured and a 3-ml volume of standard solution (1 mg/ml) was added with swirling. After standing for appropriate times (0, 1, 2, 3, 4, 6 h) 1-ml aliquots of the samples were extracted with 2 ml of acetonitrile; the obtained suspensions were vortex-mixed and centrifuged at 3000ϫg for 10 min. The supernatant was transferred to appropriate autosamplar vials and analyzed by HPLC method reported below. The prodrug concentrations were determined from the calibration curve obtained by spiking the extracts of blank plasma samples with known concentrations (Table 2) .
Analytical Procedures HPLC analysis was performed on a Lichrocart RP 18 column (particle size: 5 mm; 250ϫ4 mm i.d.; Merck, Darmstad Germany). Two isocratic elutions were used: mobile-phase 100% methanol for chemical stability and mobile-phase methanol/water 80/20 for enzymatic stability, respectively. The flow rate was set at 1.0 ml/min. Each sample containing the prodrug was filtered prior to injection using a Millex HV13 filter (Millipore) and an aliquot (20 ml) was injected into the HPLC apparatus (Hewlett-Packard chromatograph HP 1100, automatic volume injection, and DAD/UV detector) The prodrug was monitored at 260 nm. The retention time was 2.7 min. No peaks of 2 and 3 were obtained. The amounts of 2 and 3 were negligible in terms of background.
Pharmacology Ellipticine and derivative compounds are highly cytotoxic substances that kill mammalian cells at concentrations ranging from 10 Ϫ8 to 10 Ϫ6 M. These compounds form molecular complexes with DNA in vitro and are able to damage the DNA of mammalian cells by inducing double-strand breaks and DNA-protein-cross links. 16) Previous evidence suggested that ellipticine derivatives can interfere with the activity of topoisomerase II. 17) We studied the cytotoxic effects of an ellepticine derivative in human osteosarcoma SAOS cells, which lack p53, a tumor-suppressor gene product that causes cell cycle arrest in the late G 1 phase and induces apoptosis by upregulation of Waf 1 and Bax genes. 18) Materials and Methods. Cell Culture and Trypan Blue Staining Cells were growth in DMEM w/o glutammine medium (Sigma Chemical Co.) supplemented with 10% fetal bovine serum, penicillin (10 5 UI/l), streptomycin (0.10 g/l) in a 5% CO 2 humidified atmosphere at 37°C. The compound was dissolved in methanol, and added at various times to the cells in exponential phase of growth (0.15ϫ10 6 cells/plate). Nonclonogenic assay cytotoxicity was studied using the trypan blue dye exclusion test. Cells were incubated for different time in the presence of 50 mM of the compounds, and were incubated for 4 min with 0.25% trypan blue (Sigma Chemical Co.) and 5% fetal calf serum. Viable cells were identified by ability to exclude dye, whereas the dye diffuses into nonviable cells. Trypsin (0.25% Boehring Mannheim) was routinely used for subculture. It was determined dose-response curves obtained from at least three independent experiments.
Nuclear Staining with DAPI To test abilities to induce apoptosis, SAOS cells were grown on glass coverslips, after treatment rinsed in phosphate buffered saline (PBS) fixed in paraformaldehyde for 20 min at room temperature, the coverslips were incubated at room temperature in a solution of diamino-2-phenyl-indole (DAPI), after 30 min, they were washed three times in water and put on a glass slide, using Mowiol. 
